The Gemcitabine HCl market was valued at USD 749.73 Million in 2024 and is expected to reach USD 1,288.17 Million by 2032, growing at a CAGR of 7% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.